AstraZeneca Ends Production of Oxford COVID-19 Vaccine Due to Falling Demand
AstraZeneca has announced the discontinuation of its COVID-19 vaccine, Vaxzevria, developed with Oxford University, due to a significant drop in global demand. This decision follows the European Medicines Agency's withdrawal of the vaccine's marketing authorization at AstraZeneca's request.